Teijin Ltd – Strategy, SWOT and Corporate Finance Report

Teijin Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company

Key Highlights

Teijin Ltd (Teijin) is a technology driven holding company that offers solutions in the areas of information and electronics, healthcare, environment and energy and safety and protection. It manufactures and sells aramid fiber, carbon fiber products, synthetic fiber, films, polyester films, resin products, chemical products, IT products, pharmaceuticals, medical devices and water purification systems. The company offers pharmaceuticals for treating bone and joint diseases, respiratory diseases, cardiovascular and metabolic diseases, infectious and other diseases. Teijin operates facilities in America, Europe, Asia and Japan. The company sells its products in Asia, America, and Europe. Teijin is headquartered in Tokyo, Japan.

Scope

Detailed information on Teijin Ltd required for business and competitor intelligence needs

A study of the major internal and external factors affecting Teijin Ltd in the form of a SWOT analysis

An in-depth view of the business model of Teijin Ltd including a breakdown and examination of key business segments

News about Teijin Ltd, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Teijin Ltd and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Teijin Ltd as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Teijin Ltds business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

The Dow Chemical Co

Takeda Pharmaceutical Co Ltd

Sumitomo Chemical Co Ltd

Nippon Chemical Industrial Co Ltd

Mitsubishi Chemical Corp

Kaneka Corp

Hyosung Corp

Hamamatsu Photonics KK

Daiichi Sankyo Co Ltd

Celanese Corp

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Teijin Ltd - Key Facts

Teijin Ltd - Key Employees

Teijin Ltd - Key Employee Biographies

Teijin Ltd - Major Products and Services

Teijin Ltd - History

Teijin Ltd - Company Statement

Teijin Ltd - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2 Company Analysis

Company Overview

Teijin Ltd - Business Description

Business Segment: Healthcare

Overview

Performance

Business Segment: Materials

Overview

Performance

Business Segment: Others

Overview

Performance

Geographical Segment: Americas (excluding the US)

Performance

Geographical Segment: Asia

Performance

Geographical Segment: Europe and Others

Performance

Geographical Segment: Japan

Performance

Geographical Segment: PRC

Performance

Geographical Segment: The US

Performance

R&D Overview

Teijin Ltd - Corporate Strategy

Teijin Ltd - SWOT Analysis

SWOT Analysis - Overview

Teijin Ltd - Strengths

Teijin Ltd - Weaknesses

Teijin Ltd - Opportunities

Teijin Ltd - Threats

Teijin Ltd - Key Competitors

Section 3 Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 Company’s Lifesciences Financial Deals and Alliances

Teijin Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Teijin Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Teijin Ltd, Recent Deals Summary

Section 5 Company’s Recent Developments

May 14, 2019: Teijin and AMED sign R&D consignment agreement to develop drugs for Frail

Feb 04, 2019: Teijin: Consolidated financial statements summary for the the nine months ended December 31, 2018

Feb 04, 2019: Teijin Limited has made the following personnel changes effective as of June 20, 2019

May 09, 2018: Teijin: Consolidated Financial Statements Summary For the year ended March 31, 2018

Jan 04, 2018: Teijin Announces Revised Medium-Term Management Plan

Section 6 Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Tables

List of Tables

Teijin Ltd, Key Facts

Teijin Ltd, Key Employees

Teijin Ltd, Key Employee Biographies

Teijin Ltd, Major Products and Services

Teijin Ltd, History

Teijin Ltd, Other Locations

Teijin Ltd, Subsidiaries

Teijin Ltd, Joint Venture

Teijin Ltd, Key Competitors

Teijin Ltd, Ratios based on current share price

Teijin Ltd, Annual Ratios

Teijin Ltd, Annual Ratios (Cont…1)

Teijin Ltd, Annual Ratios (Cont…2)

Teijin Ltd, Interim Ratios

Teijin Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Teijin Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Teijin Ltd, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Teijin Ltd, Performance Chart (2015 – 2019)

Teijin Ltd, Ratio Charts

Teijin Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Teijin Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports